Erratum on “Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation”

Cacemiro, Maira da Costa; Cominal, Juçara Gastaldi; Tognon, Raquel; Nunes, Natalia de Souza; Simões, Belinda Pinto; Lôbo de Figueiredo-Pontes, Lorena; Bazzo Catto, Luiz Fernando; Traina, Fabíola; Xisto Souto, Elizabeth; Albani Zambuzi, Fabiana; Frantz, Fabiani Gai; de Castro, Fabíola Attié

doi:10.1016/j.htct.2020.11.001

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

Indexed in:

Web of Science, LILACS, SciELO Brazil, ESCI (Web of Science), Scopus, and PubMed/PMC

mairacacemiro@hotmail.com

Corresponding author at: Laboratório de Hematologia, Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo – USP, Av. do Café, s/n°. Campus Universitário, Ribeirão Preto, SP 14040-903, Brazil.

, Juçara Gastaldi Cominala, Raquel Tognonb, Natalia de Souza Nunesa, Belinda Pinto Simõesc, Lorena Lôbo de Figueiredo-Pontesc, Luiz Fernando Bazzo Cattoc, Fabíola Trainac, Elizabeth Xisto Soutod, Fabiana Albani Zambuzia, Fabiani Gai Frantza, Fabíola Attié de Castroa

a Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), Ribeirão Preto, SP, Brazil

b Universidade Federal de Juiz de Fora (UFJF), Governador Valadares, MG, Brazil

c Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (FMRPUSP), Ribeirão Preto, SP, Brazil

d Hospital Estadual de Transplantes Euryclides de Jesus Zerbini, São Paulo, SP, Brazil

Hematol Transfus Cell Ther. 2018;40:120-3110.1016/j.htct.2017.12.003

Maira da Costa Cacemiro, Juçara Gastaldi Cominal, Raquel Tognon, Natalia de Souza Nunes, Belinda Pinto Simões, Lorena Lôbo de Figueiredo-Pontes, Luiz Fernando Bazzo Catto, Fabíola Traina, Elizabeth Xisto Souto, Fabiana Albani Zambuzi, Fabiani Gai Frantz, Fabíola Attié de Castro

This item has received

2094 Visits

Under a Creative Commons license

Article information

Full Text

Download PDF

Statistics

Full Text

In the article “Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation”, published in Hematol Transfus Cell Ther. 2020;42(2):120–131, in the Methods section (Blood samples), where it reads:

11ET patients, 16 PMF patients, and 20PV patients”,

It should read:

“12 ET patients, 17 PMF patients, and 23PV patients”

In Table 1, ET column, where it reads:

5, it should read 6 (Male line) and where it reads 4, it should read 6 (Female line).

In Figure 1 legend, where it reads:

“essential thrombocythemia (ET; n=11), primary myelofibrosis (PMF; n=16), and polycythemia vera (PV; n=20).”,

It should read:

“essential thrombocythemia (ET; n=12), primary myelofibrosis (PMF; n=17), and polycythemia vera (PV; n=23).”

In Figure 2 legend, where it reads:

“MF patients (n=11)”,

It should read:

“MF patients (n=12)”

In Figure 5 legend, where it reads:

“myelofibrosis patients (n=16)”,

It should read:

“myelofibrosis patients (n=15)”

Indexed in:

Follow us:

Subscribe to our newsletter